
IBM · NYSE
The consensus rating is Hold, backed by 14 analysts, with a mean price target of $245; the supplied consensus provides no low or high target, so the target spread cannot be measured. No named analyst is identified as the most or least bullish, and no attributable rating or target revisions are explicitly reported during the week. The evidence does point to rising estimates around hybrid-cloud demand, Red Hat momentum, AI consulting backlog and the Sarvam sovereign-AI partnership, but it does not establish how many analysts revised forecasts or in which direction. The substantive disagreement is whether IBM’s AI and recurring-software initiatives can produce durable growth quickly enough to justify the valuation, given mainframe weakness, deal timing, leverage and dividend cash requirements.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Weiss Ratings | — | — | — | Jun 24, 2026 | Open the report this row came from |